There have been marked advances in the understanding and treatment of Turner syndrome since its initial description in 1938. Greater knowledge of the heterogeneity of phenotypes, early treatment interventions with growth hormone and hormonal replacement, the risks of reproduction, spontaneous and assisted, and the long-term health of women with Turner syndrome has been achieved in the interim. But many perplexing ethical and clinical issues persist.
|Original language||English (US)|
|Number of pages||2|
|Journal||Fertility and sterility|
|State||Published - Oct 2012|
All Science Journal Classification (ASJC) codes
- Reproductive Medicine
- Obstetrics and Gynecology